Xenobiotic Induced Model of Primary Biliary Cirrhosis

Arsenijevic, Aleksandar; Milovanovic, Jelena; Stojanovic, Bojana; Milovanovic, Marija; Gershwin, Eric M.; Leung, Patrick; Arsenijevic, Nebojsa; Lukic, Miodrag L.

doi:10.2478/sjecr-2014-0019

Abstract

Primary biliary cirrhosis (PBC) is an autoimmune disease of the liver that is, characterised by destruction of the intrahepatic bile ducts and the presence of antimitochondrial antibodies (AMAs). Several murine models of PBC, with similar serological, biochemical, and histological features to human PBC, have been developed in recent years. These animal models enable investigators to study the etiology and pathophysiologic mechanism of PBC. Immune response in PBC is directed towards E2 components of the 2-oxo-acid dehydrogenase family of enzymes, which is in located in mitochondria and is an immunodominant epitope (a lipoylated peptide sequence shared by enzymes). Immunisation of mice with 2-octynoic acid coupled to bovine serum albumin (2-OA-BSA) (which is an antigen that is structurally related to the E2 subunit of the pyruvate dehydrogenase complex [PDC-E2]) produces histologic features similar to those found in human PBC. Th is model of xenobiotic induced PBC is suitable for studying the early events in PBC pathogenesis and for developing new therapeutics in PBC.

References

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005; 353(12): 1261-1273.10.1056/NEJMra043898
Search in Google Scholar
2. Bergasa NV. Pruritus and fatigue in primary biliary cirrhosis. Clin Liver Dis. 2003; 7: 879-900.10.1016/S1089-3261(03)00105-3
Search in Google Scholar
3. Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet. 2011; 377: 1600-1609.10.1016/S0140-6736(10)61965-4
Search in Google Scholar
4. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology. 2008; 47(2): 737-745.
Search in Google Scholar
5. Hirschfield GM, Gershwin ME. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol. 2013; 8: 303-330.10.1146/annurev-pathol-020712-164014
Search in Google Scholar
6. Walker JG, Doniach D, Roitt IM, Sherlock S. Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1965; 1: 827-831.10.1016/S0140-6736(65)91372-3
Search in Google Scholar
7. Fussey SP, Guest JR, James OF, Bassendine MF, Yeaman SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc. Natl. Acad. Sci. USA 1988; 85: 8654-8658.10.1073/pnas.85.22.86542825183186751
Search in Google Scholar
8. Moteki S, Leung PS, Dickson ER, et al. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. Hepatology. 1996; 23(3): 436-444.10.1002/hep.5102303078617422
Search in Google Scholar
9. Miller FW, Alfredsson L, Costenbader KH, et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun. 2012; 39(4): 259-271.10.1016/j.jaut.2012.05.002349681222739348
Search in Google Scholar
10. Selmi C, Leung PS, Sherr DH, Diaz et al. Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun. 2012; 39(4): 272-284.10.1016/j.jaut.2012.05.00722749494
Search in Google Scholar
11. Selmi C, Balkwill DL, Invernizzi P, et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology. 2003; 38(5): 1250-1257.10.1053/jhep.2003.5044614578864
Search in Google Scholar
12. Mattner J, Savage PB, Leung P, et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe. 2008; 3(5): 304-315.10.1016/j.chom.2008.03.009245352018474357
Search in Google Scholar
13. Rieger R, Leung PS, Jeddeloh MR, et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun. 2006; 27(1): 7-16.10.1016/j.jaut.2006.06.00216876981
Search in Google Scholar
14. Wakabayashi K, Lian ZX, Leung PS, et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology. 2008; 48(2): 531-540.10.1002/hep.22390375301118563844
Search in Google Scholar
15. Wakabayashi K, Yoshida K, Leung PS, et al. Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization. Clin Exp Immunol. 2009; 155(3): 577-586.10.1111/j.1365-2249.2008.03837.x266953519094117
Search in Google Scholar
16. Ambrosini YM, Yang GX, Zhang W, et al. The multi-hit hypothesis of primary biliary cirrhosis: polyinosinicpolycytidylic acid (poly I:C) and murine autoimmune cholangitis. Clin Exp Immunol. 2011; 166(1): 110-120.10.1111/j.1365-2249.2011.04453.x319392621910728
Search in Google Scholar
17. Wu SJ, Yang YH, Tsuneyama K, et al. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology. 2011; 53(3): 915-925.10.1002/hep.24113307633421374662
Search in Google Scholar
18. Gershwin ME, Ansari AA, Mackay IR, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev. 2000; 174: 210-225.10.1034/j.1600-0528.2002.017402.x10807518
Search in Google Scholar
19. Kita H, Matsumura S, He XS, et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest. 2002; 109(9): 1231-1240.10.1172/JCI0214698
Search in Google Scholar
20. Chuang YH, Lan RY, Gershwin ME. The immunopathology of human biliary cell epithelium. Semin Immunopathol. 2009; 31(3): 323-331.10.1007/s00281-009-0172-519533127
Search in Google Scholar
21. Kimura Y, Leung PS, Kenny TP, et al. Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis. Hepatology. 2002; 36(5): 1227-1235.10.1053/jhep.2002.3615712395334
Search in Google Scholar
22. Lleo A, Invernizzi P, Mackay IR, Prince H, Zhong RQ, Gershwin ME. Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol. 2008; 14(21): 3328-3337.10.3748/wjg.14.3328271658718528930
Search in Google Scholar
23. Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase- E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest. 2001; 108(2): 223-232.10.1172/JCI200110716
Search in Google Scholar
24. Lleo A, Selmi C, Invernizzi P, et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology. 2009; 49(3): 871-879.10.1002/hep.22736266592519185000
Search in Google Scholar
25. Lleo A, Bowlus CL, Yang GX, et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology. 2010; 52(3): 987-998.10.1002/hep.23783293280920568301
Search in Google Scholar
26. Van de Water J, Gerson LB, Ferrell LD, et al. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology. 1996; 24(5): 1079-1084.10.1002/hep.5102405178903379
Search in Google Scholar
27. Van de Water J, Turchany J, Leung PS, et al. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest. 1993; 91(6): 2653-2664.10.1172/JCI1165044433298514873
Search in Google Scholar
28. Tsuneyama K, Van de Water J, Leung PS, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology. 1995; 21(4): 1031-1037.
Search in Google Scholar
29. Matsumura S, Van De Water J, Leung P, et al. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology. 2004; 39(5): 1415-1422.10.1002/hep.2017515122771
Search in Google Scholar
30. Kita H, Naidenko OV, Kronenberg M, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology. 2002; 123(4): 1031-1043.10.1053/gast.2002.3602012360465
Search in Google Scholar
31. Kita H, Lian ZX, Van de Water J, et al. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med. 2002; 195(1): 113-123.10.1084/jem.20010956219601211781370
Search in Google Scholar
32. Shimoda S, Miyakawa H, Nakamura M, et al. CD4 Tcell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun. 2008; 31(2): 110-115.10.1016/j.jaut.2008.05.00318644699
Search in Google Scholar
33. Van de Water J, Ansari A, Prindiville T, et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med. 1995; 181(2): 723-733.10.1084/jem.181.2.72321918877836925
Search in Google Scholar
34. Oo YH, Weston CJ, Lalor PF, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol. 2010; 184(6): 2886-2898.10.4049/jimmunol.090121620164417
Search in Google Scholar
35. Lan RY, Cheng C, Lian ZX, et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology. 2006; 43(4): 729-737. 10.1002/hep.2112316557534
Search in Google Scholar
36. Lan RY, Salunga TL, Tsuneyama K, et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun. 2009; 32(1): 43-51.10.1016/j.jaut.2008.11.001322505319101114
Search in Google Scholar
37. Harada K, Isse K, Nakanuma Y. Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction. J Clin Pathol. 2006; 59(2): 184-190.10.1136/jcp.2004.023507186032416443736
Search in Google Scholar
38. Shimoda S, Harada K, Niiro H, et al. CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis. Hepatology. 2010; 51(2): 567-575.10.1002/hep.23318291195919908209
Search in Google Scholar
39. Chuang YH, Lian ZX, Yang GX, et al. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology. 2008; 47(2): 571-580.10.1002/hep.2205218098320
Search in Google Scholar
40. Krams SM, Dorshkind K, Gershwin ME. Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med. 1989; 170(6): 1919-1930.10.1084/jem.170.6.191921895382584930
Search in Google Scholar
41. Irie J, Wu Y, Wicker LS, et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med. 2006; 203(5): 1209-1219.10.1084/jem.20051911212120416636131
Search in Google Scholar
42. Oertelt S, Lian ZX, Cheng CM, et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGFbeta receptor II dominant-negative mice. J Immunol. 2006; 177(3): 1655-1660.10.4049/jimmunol.177.3.165516849474
Search in Google Scholar
43. Wakabayashi K, Lian ZX, Moritoki Y, et al. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology. 2006; 44(5): 1240-1249.10.1002/hep.2138517058261
Search in Google Scholar
44. Hsu W, Zhang W, Tsuneyama K, et al. Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice. Hepatology. 2009; 49(1): 133-140.10.1002/hep.22591261445119065673
Search in Google Scholar
45. Amano K, Leung PS, Rieger R, et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol. 2005; 174(9): 5874-5883.10.4049/jimmunol.174.9.587415845458
Search in Google Scholar
46. Naiyanetr P, Butler JD, Meng L, et al. Electrophilemodified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity. J Autoimmun. 2011; 37(3): 209-216.10.1016/j.jaut.2011.06.001320614121763105
Search in Google Scholar
47. Rieger R, Leung PS, Jeddeloh MR, et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun. 2006; 27(1): 7-16.10.1016/j.jaut.2006.06.00216876981
Search in Google Scholar
48. Leung PS, Park O, Tsuneyama K, et al. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol. 2007; 179(4): 2651-2657.10.4049/jimmunol.179.4.265117675529
Search in Google Scholar
49. Leung PS, Quan C, Park O, et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol. 2003; 170(10): 5326-5332. 10.4049/jimmunol.170.10.532612734383
Search in Google Scholar

Xenobiotic Induced Model of Primary Biliary Cirrhosis

Abstract

Paradigm

My account